FMR CORP 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-06 11:14 am Sale |
2024-11-29 | 13G | Tango Therapeutics, Inc. TNGX |
FMR CORP | 13,392 0.000% |
-9,773,958 (-99.86%) |
Filing |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Tango Therapeutics, Inc. TNGX |
FMR CORP | 9,787,350 9.596% |
-3,760,722 (-27.76%) |
Filing |
| 2023-09-11 08:23 am Purchase |
2023-09-08 | 13G | Tango Therapeutics, Inc. TNGX |
FMR CORP | 13,548,072 13.326% |
4,464,393 (+49.15%) |
Filing |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Tango Therapeutics, Inc. TNGX |
FMR CORP | 9,083,679 8.291% |
1,901,491 (+26.48%) |
Filing |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Tango Therapeutics, Inc. TNGX |
FMR CORP | 7,182,188 6.593% |
7,182,188 (New Position) |
Filing |